Algo version: 0.98b
BioPharma Credit PLC is listed at the LSE Exchange
BioPharma Credit PLC [BPCP.L]
LSE Sector: Financial Services Industry:Asset Management

Is BioPharma Credit PLC stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

Yes, BioPharma Credit PLC pays dividends. Last time was Tuesday 29th of October 2024 where the investors holding the stock on Thursday 26th of September 2024 were paid GBp2.8374 per share. Over the last 30 times between 2017 and 2024, BioPharma Credit PLC has paid GBp48.905449 with an average of GBp1.63 per share.

Sorry, we do not have any analyst data for this ticker

We cannot find data for BioPharma Credit PLC 10 years ago, but if you had invested on Friday 22nd of November 2019 when the price was GBp100.00, you would have made a loss of GBp-31.10 per share or -31.10%

Yes, the average daily trading liquidity for BioPharma Credit PLC is GBp14 700 thousand. You should therefore be able to get in and out of your positions relatively fast.

BioPharma Credit PLC has no real debt, which is good in periods of high inflation. BioPharma Credit PLC has a very good net profit margin of 80.20% and should have very high tolerances against inflation.

We have calculated the inflation risk for BioPharma Credit PLC to be low [0.3 of 1]

US inflation for August 2024 was 0.19%. Over the last 12 months, the US inflation is 2.59%. The 10-year treasury yield that indicates the future interest level is currently 4.41 and is up 0.05 over the last 30 days.